Introduction {#S1}
============

In every environment where life exists, competition is a critical evolutionary driving force of all organisms from Darwin's finches to simple microbes^[@R1]^. Microbes employ offensive weapons, such as producing antibiotics that inhibit neighbouring bacteria and, in response, bacteria have evolved defensive mechanisms to repair injuries and survive in hostile environments. These include specific resistance genes that inhibit antibiotic activity or nonspecific resistance pathways, such as producing exopolysaccharides (EPS) and biofilms or using envelope stress responses (ESRs) to recognize cellular damage and coordinate repair regulons. These systems have demonstrated protection against antibiotics and other cellular stressors, yet in the natural environment -- where encountering an antibiotic might be rare -- the evolutionary pressures selecting for these defences can be unclear.

The type six secretion system (T6SS) is a molecular weapon that injects toxic effector proteins into neighbouring cells to kill and out-compete them^[@R2],[@R3]^. Resembling a molecular spear, a contractile outer sheath thrusts a long tube forward and out of the attacking 'killer' cell. Tipped by a VgrG protein trimer and further sharpened by a PAAR-domain containing protein, this tube physically punctures 'prey' cells to deliver the toxic cargo, which are often attached or covalently fused to the VgrG or PAAR proteins. These effectors have a variety of targets in both eukaryotic and prokaryotic prey and most bacteria with a T6SS produce several effectors with multiple molecular targets. *V. cholerae* O37 strain V52 constitutively expresses its T6SS and encodes five effectors^[@R2],[@R4]--[@R6]^. The most recently identified, TseH, is a peptidoglycan hydrolase encoded outside of the main T6SS operons and likely acquired by horizontal gene transfer^[@R4]^.

The best understood defence against T6SS attacks is self-protection conferred by immunity proteins, which neutralize specific effector toxicities^[@R3],[@R7],[@R8]^. Usually encoded directly adjacent to their cognate effector, immunity genes are considered the gold standard of defence and in previous works their expression has consistently proven sufficient to survive a T6SS attack by their associated bacteria-targeting effector. Accordingly, deletion of an immunity gene renders the cell susceptible to killing by the effector; for instance in V52 where deletion of *tsiV1*, *tsiV2*, or *tsiV3* cause the bacteria to be killed by TseL, VasX, or VgrG3 (respectively)^[@R5]^. An immunity gene (*tsiH*) is encoded downstream of *tseH* but its deletion did not reduce survival when attacked by wild-type V52, nor did deletion of *tseH* affect killing of *E. coli* prey that lack T6SS immunity genes entirely^[@R4]^. This raises the question of why do bacteria maintain cryptic effectors in their genome if they do not show activity when delivered by the T6SS?

Here we demonstrate that *V. cholerae* deploys TseH to outcompete specific species sharing common ecological niches. We report that TseH is a PAAR-dependent chaperone-independent effector highly toxic to *Aeromonas* and *Edwardsiella* species. We determine that *E. coli* is protected against TseH activity by two ESR pathways, BaeSR and Rcs. Expressing a BaeSR-regulated chaperone, Spy, also protects otherwise susceptible *A. dhakensis*. Surprisingly, the ESR in *V. cholerae,* WigKR (also known as VxrAB), is critical to survive self-killing by its own T6SS despite expressing a full complement of immunity genes. Considering that the T6SS can greatly influence survival of bacteria in mixed populations, including a significant role in host colonization by pathogens such as *V. cholerae*^[@R9]--[@R12]^, and that the T6SS is encoded by about 25% of gram-negative bacteria^[@R13]^, including co-inhabitants in various niches, our results impact a wide range of bacteria and highlight the striking microbial arms-race selecting for acquisition of effectors and immunity-independent envelope stress protection mechanisms.

Results {#S2}
=======

TseH is a PAAR-dependent effector displaying species-specific killing {#S3}
---------------------------------------------------------------------

The *V. cholerae* T6SS effector, TseH, is encoded adjacent to a PAAR protein (PAAR2) but isolated from other known T6SS components. In previous T6SS competition assays, TseH did not show any killing activity of *V. cholerae* lacking the immunity gene (*tsiH*), nor did it influence killing of *E. coli*^[@R4]^. Contrastingly, high concentrations of TseH during overexpression with a periplasmic localization (TAT) tag was able to kill *E. coli*, suggesting that it is an active effector but *E. coli* and *V. cholerae* are able to survive its damage at T6SS-delivered concentrations^[@R4]^. To isolate the activity of TseH we employed a V52 strain with catalytic mutations in all other antibacterial effectors: TseL, VasX and VgrG3^[@R14]^. This strain (called TseH^WT^ in this work) retains TseH activity and T6SS function but does not kill *E. coli* or *V. cholerae* Δ*tsiH* prey ([Fig. 1a](#F1){ref-type="fig"}).

We considered that perhaps TseH could show species-specific killing against bacteria that *V. cholerae* encounters in natural environments or common hosts. We tested waterborne bacteria prey, including *Edwardsiella* and *Aeromonas* species (the latter shares a marine host with *V. cholerae*^[@R15]^), and several were highly susceptible to TseH-mediated toxicity ([Extended Data Fig. 1a](#F7){ref-type="fig"}). Active TseH killed 100-fold more *A. dhakensis* SSU than the catalytically inactive mutant (TseH^H64A^), which showed as little killing as a strain lacking T6SS activity ([Fig. 1a](#F1){ref-type="fig"}). Killing was due to TseH activity, as expression of the immunity gene protected *A. dhakensis* ([Extended Data Fig. 1b](#F7){ref-type="fig"}), and complementation with exogenous wild-type TseH restored killing to the TseH^H64A^ strain ([Extended Data Fig. 1c](#F7){ref-type="fig"}).

Due to their genetic linkage, TseH has been proposed to require PAAR2 for secretion^[@R4]^. We demonstrate that TseH requires PAAR2 for its delivery, as deletion or truncation of PAAR2 prevented TseH-mediated killing ([Fig. 1b](#F1){ref-type="fig"}, [Extended Data Fig. 1d](#F7){ref-type="fig"}). Notably, despite using the TseH^WT^ background, deletion of PAAR2 likely influenced TseH expression, as both PAAR2 and TseH plasmids were required for complementation. Interestingly, the *tseH* operon does not include a T6SS chaperone protein and pull-down assays in *E. coli* suggest that the interaction between PAAR2 and TseH can occur in the absence of other T6SS proteins ([Extended Data Fig. 1e](#F7){ref-type="fig"}). This demonstrates chaperone-independent delivery by a PAAR protein.

Crystal structure of TseH {#S4}
-------------------------

We determined the crystal structure of TseH and identified random mutations reducing its toxicity that arose during cloning (see [Methods](#S13){ref-type="sec"}) ([Fig. 1c](#F1){ref-type="fig"}-[d](#F1){ref-type="fig"}, [Extended Data Fig. 2](#F8){ref-type="fig"}). TseH exhibits the bi-lobal architecture of papain-like NlpC/P60 enzymes with the catalytic center and substrate binding pocket at the interface of N- and C-terminal lobes ([Extended Data Fig. 1f](#F7){ref-type="fig"}). According to the structural similarity Dali server^[@R16]^ the closest structural homologues of TseH among NlpC/P60 enzymes are representatives of YaeF/Poxvirus G6R subfamily, specifically *E. coli* metalloprotein YiiX (PDB: 2IF6, Z score of 9.3), *B. cereus* cysteine protease (PDB: 3KW0, Z score of 7.8) and human hydrolase PPPDE1 (PDB: 3EBQ, Z score of 7.7). The activity of these enzymes has not been characterized^[@R17]^. There is also structural similarity between TseH and Tse1, another T6SS effector that belongs to NlpC/P60 and was shown to degrade peptidoglycan^[@R18]^. TseH and Tse1 structures superimpose with RMSD of 4.11 Å^[@R2]^ over 71 Cα atoms yet the N- and C-terminal lobes appear swapped^[@R18],[@R19]^. Several NlpC/P60 superfamily members are similarly swapped at the primary sequence while retaining relative tertiary positions^[@R20]^.

TseH residues Glu81 and His64 (N-terminal lobe) and Cys172 (C-terminal lobe) correspond to the catalytic triad in the conserved papain-like protease fold in NlpC/P60 superfamily^[@R20]^. Notably, while TseH Cys172 is solvent accessible in accordance with its proposed nucleophile role, the active site opening appears very narrow due to a long loop connecting β1 and β2 strands directly above the catalytic cysteine^[@R16]^. This configuration would preclude the access to large substrate molecules such as polypeptide. It is possible that the observed configuration is part of a regulatory "safety switch" mechanism, which have been reported for other NlpC/P60 superfamily proteins such as the peptidoglycan endopeptidase SaCwlT^[@R21],[@R22]^. The active site of SaCwlT in apo form is occluded ([Extended Data Fig. 1g](#F7){ref-type="fig"}) and it has been suggested that a change in rotomer conformations controls substrate access^[@R21],[@R22]^. The only apparent interaction stabilizing TseH loop conformation is hydrogen bonding through Arg84, suggesting significant flexibility of this element.

Envelope stress responses protect *E. coli* against T6SS-delivered TseH {#S5}
-----------------------------------------------------------------------

Since TseH was able to kill *Aeromonas* and *Edwardsiella* species, it is remarkable that the TseH^WT^ strain showed no activity against other bacteria including *E. coli* and Δ*tsiH V. cholerae*. We confirmed that overexpression of periplasm-directed TseH caused lysis of *A. dhakensis* or *E. coli*, indicating that it is active even in the resistant species ([Extended Data Fig. 3a](#F9){ref-type="fig"}-[b](#F9){ref-type="fig"}) and led to apparent peptidoglycan degradation ([Video 1](#SD2){ref-type="supplementary-material"})^[@R4]^. We therefore hypothesized that *E. coli* survives TseH attacks at T6SS-delivered concentrations by encoding defences capable of mitigating the damage. *E. coli* encodes five ESRs including the Rcs phosphorelay and the BaeSR two-component system, which can respond to cell wall damage^[@R23],[@R24]^ potentially caused by TseH. Using *E. coli* ESR mutants^[@R25]^ as prey, we found that deletion of the response regulators *rcsB* or *baeR* rendered *E. coli* sensitive to killing by *V. cholerae* TseH, significantly reducing survival ([Fig. 2a](#F2){ref-type="fig"}). Complementation by exogenous expression of the deleted genes restored survival ([Fig. 2b](#F2){ref-type="fig"}). Impairing other ESRs (*cpxR* and *pspF*), the general stress response (*rpoS*), or the *soxRS* reactive oxygen defence, did not reduce survival ([Fig. 2a](#F2){ref-type="fig"}, [Extended Data Fig. 3c](#F9){ref-type="fig"}). These data indicate that the Rcs and BaeSR ESRs are critical for complete survival of *E. coli* against T6SS-delivered TseH.

Rcs protection against TseH involves osmotic response genes and colanic acid capsule synthesis {#S6}
----------------------------------------------------------------------------------------------

To identify how RcsB and BaeR support *E. coli* survival against TseH, we examined additional knockout strains^[@R25]^. Multiple genes regulated by RcsB^[@R26]^ played a role in protecting against TseH-mediated killing, as survival of the mutant strains was significantly reduced ([Fig. 2c](#F2){ref-type="fig"}, [Extended Data Fig. 3c](#F9){ref-type="fig"}). These included *osmB* and *bdm,* which respond to osmotic stress, a potential consequence of peptidoglycan damage^[@R27],[@R28]^. Moreover, deletion of genes involved in colanic acid synthesis (*wza* and *wcaA*) reduced survival, suggesting that this Rcs-induced EPS protects *E. coli* against T6SS attacks. Deletion of the *wcaJ* gene, resulting in loss of colanic acid while also abolishing potentially toxic intermediates during its synthesis^[@R29]^, also showed reduced survival compared to wild-type with a nearly significant p-value of 0.0527 ([Extended Data Fig. 3c](#F9){ref-type="fig"}); however this difference in severity suggests that accumulating intermediates may further sensitize the *wza* and *wcaA* mutants to TseH. Importantly, the colanic acid synthesis operon was induced in *E. coli* prey when catalytically active TseH (compared to TseH^H64A^) was delivered by the T6SS ([Fig. 2d](#F2){ref-type="fig"}). While other genes did not show significant induction ([Extended Data Fig. 3d](#F9){ref-type="fig"}), this suggests that at least part of the defence against T6SS attacks is mediated by an active response to TseH damage.

To further demonstrate the role of a colanic acid capsule in protecting against T6SS attacks, we overexpressed the Rcs auxiliary component, RcsA, which has been shown to induce colanic acid synthesis resulting in capsule formation and mucoid colonies^[@R30],[@R31]^. We examined the survival of *rcsA*-overexpressing *E. coli* against the T6SS of wild-type *V. cholerae* V52 with all four antibacterial effectors intact and active. Remarkably, overexpressing *rcsA* protected *E. coli* up to 10,000-fold compared to the vector only control ([Fig. 2e](#F2){ref-type="fig"}). This protection did not occur in the *ΔwcaJ* background, demonstrating that expressing a colanic acid capsule can significantly defend *E. coli* against T6SS attacks despite lacking immunity genes. Interestingly, the defensive mechanism of the colanic acid capsule is likely via deflecting incoming attacks, as it could not protect against endogenously expressed TseH ([Extended Data Fig. 4a](#F10){ref-type="fig"}).

The BaeSR-regulated periplasmic chaperone, Spy, provides cross-species protection against TseH {#S7}
----------------------------------------------------------------------------------------------

In contrast to RcsB, we did not identify any individual knockouts from the BaeR regulon^[@R26],[@R32]^ that showed impaired survival against TseH, suggesting that the key BaeR-regulated defensive gene was not included in our targeted screen or that the regulon as a whole was able to compensate for the loss of a single member ([Fig. 2c](#F2){ref-type="fig"}, [Extended Data Fig. 3c](#F9){ref-type="fig"}). However, we observed that maintaining envelope integrity was important for surviving TseH attacks, as deletion of several genes involved in this process showed impaired survival when challenged with the TseH^WT^ strain. These included the periplasmic protease and chaperone, DegP^[@R33]^, the most sensitive *E. coli* mutant identified.

Since a prominent member of the BaeSR regulon is the periplasmic chaperone, Spy^[@R26],[@R32],[@R34],[@R35]^, we hypothesized that it may play a role in protecting against TseH. Though deletion of *spy* alone did not reduce *E. coli* recovery ([Fig. 2c](#F2){ref-type="fig"}), we considered that expression of Spy may support overall envelope integrity to improve survival against TseH. We found that plasmid-borne exogenous BaeR fully protected sensitive *E. coli* mutants even with basal levels of expression ([Fig. 2f](#F2){ref-type="fig"}). Moreover, while other members of the BaeR regulon did not improve survival of the highly sensitive Δ*degP* mutant ([Extended Data Fig. 4b](#F10){ref-type="fig"}), overexpression of Spy protected the Δ*degP* strain and other sensitive *E. coli* mutants against TseH ([Fig. 2f](#F2){ref-type="fig"}). While it is important to consider that this only occurred with overexpressed levels of Spy, we found that exogenous overexpression of *E. coli* Spy (but not BaeR) was also able to show cross-species protection in *A. dhakensis*, which lacks an obvious Spy homolog ([Fig. 2f](#F2){ref-type="fig"}). How Spy overexpression conveys this protection remains unclear, but Spy did not interact with TseH in a pull-down assay ([Extended Data Fig. 1e](#F7){ref-type="fig"}), and appeared to slightly -- though not significantly (p = 0.0513) -- improve cell permeability measured using propidium iodide ([Extended Data Fig. 4c](#F10){ref-type="fig"}-[d](#SD12){ref-type="supplementary-material"}).

The WigKR ESR protects *V. cholerae* against TseH {#S8}
-------------------------------------------------

TseH was also unable to kill *V. cholerae* lacking the immunity gene, *tsiH* ([Fig. 1a](#F1){ref-type="fig"} and Altindis *et al.*^[@R4]^). Since *V. cholerae* lack the Rcs phosphorelay and BaeSR, we predicted that another ESR might similarly protect against TseH. *Vibrio* species encode a two-component system called WigKR (VxrAB) that can respond to cell wall damage and induce peptidoglycan repair genes^[@R36],[@R37]^.

To investigate the role of WigKR in *V. cholerae*'s survival against TseH, we first employed periplasm-directed (TAT-tagged) TseH expressed from an arabinose-inducible plasmid. Interestingly, while wild-type V52 was not inhibited, overexpression of TseH in the *wigR* knockout strain yielded a distinct zone of clearance ([Fig. 3a](#F3){ref-type="fig"}). Importantly, the Δ*tsiH* mutant showed no zone of clearing, suggesting that the protective effect of WigR is independent of TsiH. We next tested whether WigKR was responsible for *V. cholerae* surviving T6SS-mediated delivery of TseH. Individually, neither the Δ*wigR* nor the Δ*tsiH* mutants were sensitive to killing by T6SS-delivered TseH but the double mutant lacking both defences showed significantly reduced survival ([Fig. 3b](#F3){ref-type="fig"}). This sensitivity could be complemented by expression of exogenous *wigR*, confirming that either the immunity protein or the WigKR ESR can provide sufficient protection to prevent killing by T6SS-delivered TseH.

WigKR is necessary for *V. cholerae* survival against its own wild-type T6SS, despite the presence of immunity genes {#S9}
--------------------------------------------------------------------------------------------------------------------

Since deletion of *wigR* rendered V52 sensitive to endogenous overexpression of TseH despite TsiH, we wondered if it plays a necessary role in protecting *V. cholerae* against self-killing by its own effectors even in the presence of immunity genes. Strikingly, we found that WigKR was crucial for protecting *V. cholerae* against its own effectors, as deletion of *wigR* significantly reduced survival during competition with wild-type V52, and exogenous WigR expression complemented this sensitivity ([Fig. 3c](#F3){ref-type="fig"}). We observed sensitivity of *wigR* mutants to T6SS-mediated killing with ΔT6SS ([Fig. 3c](#F3){ref-type="fig"}) or wild-type V52 prey ([Extended Data Fig. 5a](#F11){ref-type="fig"}), and with pandemic *V. cholerae* O1 *El Tor* C6706 prey ([Extended Data Fig. 5b](#F11){ref-type="fig"}). Importantly, this kin-killing of *wigR* mutants occurred despite the prey strain encoding a full array of immunity genes. While expression of immunity genes was slightly lower in the *wigR* mutant ([Extended Data Fig. 5c](#F11){ref-type="fig"}), the Δ*wigR* strain also showed significantly reduced survival in a background lacking the immunity genes *tsiV1*-*3* ([Fig. 3d](#F3){ref-type="fig"}) and when attacked by the T6SS of *A. dhakensis* ([Fig. 3e](#F3){ref-type="fig"}), against which *V. cholerae* has no immunity. Thus the protective role of WigR is independent of immunity genes.

The protective role of WigKR supersedes VPS expression {#S10}
------------------------------------------------------

Similar to the Rcs pathway in *E. coli*, WigKR has been shown to positively regulate biofilm formation and synthesis of *Vibrio* polysaccharide (VPS)^[@R38]^.A recent study showed that loss of VPS renders *V. cholerae* immunity mutants further sensitive to T6SS activities^[@R39]^. Thus, in addition to its role in peptidoglycan repair, WigKR may also mediate protection against T6SS attacks via a VPS capsule. To examine this, we induced VPS synthesis in *V. cholerae* V52 by growing this strain at 30 °C, yielding cellular aggregates in a *vpsA* (a gene essential for VPS biosynthesis)-dependent manner ([Extended Data Fig. 5d](#F11){ref-type="fig"})^[@R40]^. Indeed, V52 lacking immunity genes or facing a T6SS attack by *A. dhakensis* (which is mutually destructive with *V. cholerae* when both encode an active T6SS^[@R41]^) were highly sensitive to killing when pre-grown at 37 °C but were impressively protected after growth at 30 °C ([Fig. 4a](#F4){ref-type="fig"}, [b](#F4){ref-type="fig"}). This protection was largely dependent on VPS, as the equivalent Δ*vpsA* mutants showed significantly reduced survival. However, even after growth at 30 °C, the *wigR* mutant remained sensitive to its own T6SS regardless of *vpsA*, and deletion of *vpsA* had no effect on V52 survival against its own T6SS when all immunity genes remained intact ([Fig. 4c](#F4){ref-type="fig"}). This demonstrates that the protective ability of WigKR is not solely due to VPS regulation, but rather supersedes it.

WigKR is required for T6SS expression in *V. cholerae* V52 {#S11}
----------------------------------------------------------

In addition to its role in repairing peptidoglycan^[@R36],[@R37]^, mediating VPS and biofilm formation^[@R38]^, and now defending against T6SS attacks, the WigKR system has also been shown to influence T6SS expression in *V. cholerae El Tor* strains that do not constitutively express their T6SS^[@R42]^. We examined if it is also involved in T6SS expression in V52 and indeed found that Δ*wigR* V52 was greatly impaired in its ability to kill *E. coli* prey ([Fig. 5a](#F5){ref-type="fig"}). This reduced killing activity was reflected at both protein and mRNA levels as Δ*wigR* V52 produced fewer T6SS needles ([Fig. 5b](#F5){ref-type="fig"}) and had reduced expression of T6SS genes, *hcp* and *vipA,* compared to wild-type ([Fig. 5c](#F5){ref-type="fig"}). This demonstrates that even the constitutive T6SS expression in V52 relies substantially on WigKR.

Discussion {#S12}
==========

In this work we demonstrate that TseH is a PAAR-dependent species-specific effector, and establish that ESRs play a significant role in protecting bacteria against T6SS attacks. Protection occurred both in the presence and absence of immunity genes, demonstrating that immunity genes are not always necessary or sufficient to survive incoming T6SS attacks, even from neighbouring kin bacteria. We highlighted specific ESRs (Rcs and BaeSR in *E. coli*, and WigKR in *V. cholerae*) that protect against a T6SS effector, TseH, and discovered that WigKR (VxrAB) is necessary for *V. cholerae* to survive attacks from its own T6SS despite expressing a full complement of immunity genes. Exemplified here, similar systems likely exist in many species encoding or encountering attacks from a T6SS.

We also identified protective mechanisms mediated by these ESRs, including by maintaining envelope integrity, osmotic response genes, and inducing EPS capsule synthesis, potentially improving the cell's ability to resist lysis and deflect further incoming attacks. These ESRs likely also regulate genes that can repair effector-mediated damage, as WigKR has been shown to induce peptidoglycan synthesis^[@R36],[@R37]^. Full protection is likely a combination of active response to damage and preparing the cell before encountering attacks. The importance of maintaining cell envelope integrity in surviving T6SS attacks was highlighted by the pronounced susceptibility of Δ*degP E. coli* to TseH, and potentially by the ability of Spy to protect various sensitive *E. coli* mutants and *A. dhakensis* from TseH. While the exact mechanisms underlying these protections require further investigation, they might involve a healthy envelope providing a buffer of time to repair effector-mediated damage before the envelope fails and the cell lyses.

Since TseH showed killing activity against most *Aeromonas* strains tested, it may grant a competitive advantage to *V. cholerae* in aquatic and marine host environments shared with *Aeromonas* species^[@R15],[@R41]^. While the basis of *Aeromonas*' sensitivity to TseH was not fully elucidated, they notably do not encode Spy or any of the three defensive ESRs recognized in this work ([Extended Data Fig. 5e](#F11){ref-type="fig"}), suggesting that *Aeromonas* may simply lack defences capable of adequately mitigating TseH-inflicted damage. The finding that *E. coli* Spy can protect *A. dhakensis* also supports the concept that they may have simply not yet evolved a coordinated defence against TseH. Cryptic T6SS effectors from other bacteria may show similar species-specific killing when targeting prey that lack defences.

We also noted that wild-type *V. cholerae* (encoding all immunity genes and WigKR) showed impaired survival against the V52 T6SS when the prey were in stationary phase ([Fig. 3c](#F3){ref-type="fig"}, [Extended Data Fig. 5a](#F11){ref-type="fig"}-[b](#F11){ref-type="fig"}), suggesting that T6SS attacks against less metabolically active cells can overwhelm their defences. This sensitivity also existed in our prey strain lacking the immunity genes *tsiV1--3* ([Fig. 3d](#F3){ref-type="fig"}), suggesting it was not due to reduced immunity gene expression as previously implicated for *Myxococcus xanthus*^[@R43]^. Therefore, nonspecific defences may be impaired by nutrient limitation, especially energy-costly defences such as synthesizing EPS.

WigKR also regulates T6SS expression as shown previously for *El Tor* biotype *V. cholerae*^[@R42]^ and in this work for V52. This proposes the possibility that *V. cholerae* may use WigKR to sense incoming attacks (or environments where attacks are likely) and induce T6SS expression as a potential counterattack. This type of T6SS counterattack has precedent in *Serratia marcescens*, wherein reactive T6SS induction was mediated by the Rcs phosphorelay^[@R44]^. However, unlike WigKR, the Rcs pathway was not required for survival of *S. marcescens* during intraspecies competition and its role for interspecies competition remains unclear. Importantly, WigKR is also important during *V. cholerae* host colonization^[@R42]^, where its role in T6SS regulation and defence could tilt the balance against the host microbiome to help the pathogen establish infection.

Cumulatively, our findings highlight that beyond immunity genes nonspecific resistance to T6SS attacks exists in both T6SS-encoding and T6SS-lacking bacteria. This implies an evolutionary rationale for attacking cells to encode multiple T6SS effectors with divergent molecular targets to not only synergize with each other^[@R45]^ but also to overwhelm nonspecific defences. The T6SS is widespread -- suggesting that bacteria are often subjected to T6SS attacks -- and such a common selective pressure is expected to drive the evolution of defence mechanisms against it. Indeed, a few recent works have shown that forming kin-only clusters can prevent intoxication^[@R41],[@R46]^, oxidative stress responses can limit prey mortality^[@R47]^, and *V. cholerae* VPS mutants are more susceptible to incoming T6SS attacks^[@R39]^. Though knowledge of non-immunity defence mechanisms is just scratching the surface they are likely as commonplace as the molecular weapon itself, fundamentally impacting bacterial T6SS interactions involving a wide variety of bacteria in the environment, amongst healthy microbiota, and during pathogen host colonization. ESRs and EPS are well known to protect against antibiotics and other cellular stressors, and here we propose that the T6SS also had a major influence on their evolution. This has important implications on how bacterial ecosystems have evolved, how stress responses and capsules impact survival in multispecies communities (including microbiomes resisting pathogen colonization), and reveals the possibility of targeting these defence pathways with next generation antibiotics to sensitize pathogenic bacteria not only to antibiotics but also to the T6SS of their neighbouring kin and competitors.

Methods {#S13}
=======

Bacterial strains and plasmids {#S14}
------------------------------

Strains and plasmids used in this study are listed in [Supplementary Information Table 1](#SD1){ref-type="supplementary-material"}. Unless otherwise indicated, cells were grown shaking at 37 °C in LB media (0.5% NaCl) or on LB agar plates. Antibiotics were added for prey cell recovery or plasmid maintenance where required to final concentrations of 25 μg/mL chloramphenicol (for *E. coli*), 2.5 μg/mL chloramphenicol (for *V. cholerae* and *A. dhakensis*), 100 μg/mL carbenicillin, 50 μg/mL kanamycin, 5 μg/mL erythromycin. Plasmids and suicide vectors for chromosomal recombination were generated using standard molecular biology techniques and verified by Sanger sequencing. The *V. cholerae* Δ*wigR* (*vxrB)* mutant was also verified by whole genome Illumina sequencing to confirm that there were no secondary mutations. Random mutations in plasmid-borne TAT-TseH that likely reduce toxicity were identified during cloning in the absence of glucose repression. These were sequenced and point mutations are listed in [Extended Data Fig. 2.](#F8){ref-type="fig"}

T6SS competition assay {#S15}
----------------------

Assessment of T6SS activity was conducted as described previously with minor modifications^[@R48]^. In brief, 'killer' strains and log phase 'prey' strains were subcultured 1/100 from overnight cultures for 3 hours (to an OD~600nm~ \~ 1.0 -- 1.5). Unless indicated, prey strains were from overnight cultures. Where indicated, V52 prey were grown at 30 °C to induce VPS expression. Killer and prey were mixed at a 10:1 ratio (unless otherwise stated in the figure legend), spotted on LB plates and incubated for 3 hours at 37 °C. VPS-induced cultures were pipetted and vortexed thoroughly to break up cellular aggregates prior to mixing with killer cells. Agar plugs containing the mixed bacteria were removed using wide-bore pipette tips, resuspended in PBS, serially diluted and plated for colony forming units (CFU). Data is reported as either a log CFU recovered or as a ratio of log CFU recovered relative to that with the TseH^H64A^ or ΔT6SS control killer strains. For plasmid expression in prey cells, 0.1% arabinose or 1mM IPTG was included in the co-incubation plate. For plasmid expression in killer cells, 0.4% arabinose was included in the subculture and 0.1% arabinose was included in the co-incubation plate. For selective plating of prey CFU: plasmids for complementation were used as selective markers, *E. coli* wild-type, *V. cholerae* and *A. dhakensis* prey include pBAD33k as a selective marker, *E. coli* mutants encode chromosomal kanamycin resistance, *Aeromonas* species were selected by natural ampicillin resistance, *Edwardsiella* strains were selected by natural erythromycin resistance. Importantly, strains used as consistent controls across many experimental days have additional replicates and all are displayed in the data presented.

Disk diffusion assay {#S16}
--------------------

Plasmid encoding arabinose inducible TAT-tagged (periplasm-directed) TseH was freshly electroporated into strains of interest and maintained on 0.4% glucose to repress expression. Fresh colonies were resuspended in LB media and used to plate a bacterial lawn using a cotton swab. Sterile 16mm disks were placed on top of the inoculated agar and 50 μl of 40% arabinose or glucose (as indicated) was spotted onto the centre of the disk. Plates were imaged after overnight growth at 37 °C.

Microscopy {#S17}
----------

Microscopy was conducted as described previously^[@R49]^. In brief, overnight cultures were diluted 1/100 in fresh LB, grown to an OD~600nm~ of approximately 1.0, resuspended to an OD~600nm~ of 10 and spotted onto a 1% agar pad in 0.5 × PBS. Imaging was conducted on a Nikon Ti-E inverted microscope using NIS-Elements AR 4.40 software, and Fiji was used for image analysis. For WigR complementation, 0.4% arabinose was added to the subculture. For peptidoglycan visualization in [Video 1](#SD2){ref-type="supplementary-material"}, cells were concentrated to OD~600~ of 20 and stained with 100 μg/mL Wheat Germ Agglutinin (WGA) Alexa Fluor™ 488 Conjugate. Cells were spotted onto 1% agarose pads supplemented with diluted LB (1:5), PBS buffer (1:2), and 1 mM IPTG (for TseL and VgrG3 induction) or 0.2% L-arabinose (for TseH induction). Time lapse images were taken every 20 seconds for 25 minutes. For examining propidium iodide permeability, cells were resuspended in 0.5X PBS to OD~600~ of 15, stained with 0.5 μg/ml propidium iodide (PI) stain and spotted on 1% agarose-0.5X PBS pads for imaging.

RT-qPCR {#S18}
-------

For measuring gene expression in *V. cholerae*, strains were grown to an OD~600~ of approximately 1.1. For measuring gene expression in *E. coli* in response to *V. cholerae*-delivered TseH, a T6SS competition assay was conducted at a 2:1 killer:prey ratio; after 3 hours samples were scraped off the competition plate with a sterile loop, resuspended in LB, and prepped for RT-qPCR. Samples were prepped for RT-qPCR by lysing with hot SDS (1% SDS, 2 mM EDTA) and mixing with an equal volume of hot acidic phenol (pH 4.5). Phenol mixtures were incubated at 65 °C for 5 minutes followed by 5 minutes on ice before the phases were separated by centrifugation. RNA was purified from the aqueous phase with a Direct-zol RNA MiniPrep kit (Zymo Research). Reverse transcription was performed with SuperScript IV Reverse Transcriptase (Invitrogen) and qPCR was performed with Fast SYBR Green Master Mix (Applied Biosystems) in technical triplicate. Relative quantification was performed using a standard curve and the 16s rRNA gene, *rrsA*, was used as an internal standard. For *E. coli* response to *V. cholerae*-delivered TseH, *E. coli*-specific primers (including for 16s rRNA) were used.

Crystallography {#S19}
---------------

*E. coli* BL21 (DE3) gold cells containing pET-SUMO-TseH were grown in 1 L LB media supplemented with ampicillin at 37 °C. Cytoplasmic TseH showed no toxicity to *E. coli*, enabling TseH overexpression and purification, followed by crystallization by a vapor diffusion approach in the presence of thermolysin as described previously^[@R50]^. Expression was induced by addition of 1 mM IPTG at OD~600~\~0.5--0.7. The culture was continuously shaken overnight at 20 °C. Cells were collected by centrifugation and pellets resuspended in PBS buffer supplemented with 30 mM imidazole, DNaseI, PMSF, benzamidine and 0.5 mM TCEP. Subsequently the cells were lysed by Avastin (15,000psi). Debris were centrifuged and the supernatant was passed through Ni-NTA (ThermoFisher) resin by gravity flow. The resin was washed with 20 CV of wash buffer (50 mM sodium phosphate buffer pH 7.6, 300 mM NaCl, 50 mM imidazole, 0.5mM TCEP). The protein was eluted with 2 CV of elution buffer (wash buffer supplemented with 300 mM imidazole). The SUMO tag was cleaved by SUMO protease while dialyzing out imidazole overnight (Dialysis buffer: 10 mM HEPES pH 7.4, 300 mM NaCl, 0.5 mM TCEP). The cleaved TseH was separated from SUMO-tag, SUMO protease and uncleaved TseH by applying back to Ni-NTA resin. The flow through was collected and concentrated to 27 mg/ml prior to crystallization. Se-Met derivatized TseH was purified using the same protocol as above except that the protein was expressed using M9 high-yield growth procedure according to the manufacturer's instructions (Shanghai Medicilon).

Native and Se-Met derivatized TseH were crystallized by using in situ proteolysis using Thermolysin^[@R50]^. TseH was incubated with thermolysin in a ratio of 1:1000 (wt) on ice for 30 min prior to setting up crystallization. The crystals were obtained by mixing TseH and mother liquor (18% w/v PEG8000, 0.2 M calcium acetate and 0.1 M sodium cacodylate pH 6.5) in 1:1 ratio at 22 °C. The crystal appeared overnight and matured in 1--2 weeks. The crystals were briefly transferred to cryo protectant containing the mother liquor and 30% glycerol, then flash frozen in liquid nitrogen. Native and Se-Met X-ray diffraction data were collected at Canadian Light Source (CMCF-08B1).

Diffraction data were processed using HKL3000 suite, XDS suite, Aimless^[@R51]--[@R53]^. Only the data up to 4.0 Å were used for obtaining crystallographic phase information using multiple anomalous dispersion method (MAD). Initial phase and atomic model were calculated using AutoSHARP^[@R54]^. Final figure of merit was 0.72563 (acentric)/049611 (Centric). The high resolution native structure was determined using Phenix.phaser^[@R55]^ with the partially built model from AutoSHARP. Model refinement was completed using Phenix.refine^[@R55]^ and Coot^[@R56]^. All B-factors were refined as isotropic with TLS parameterization. All geometry was verified using Phenix validation tools (Ramachandran statistics: Favoured \[97.2%\], additionally allowed \[2.8%\], disallowed \[0.0%\]) and the wwPDB server. Further information and statistics about the structure are listed in [Extended Data Fig. 6](#F12){ref-type="fig"}.

Pull-down assay {#S20}
---------------

Pull-down assays were conducted as described previously^[@R57]^. In brief, *E. coli* BL21 DE3 with plasmids encoding TseH-Flag and either PAAR2-His or Spy-His were grown to mid-log phase, induced for expression with 1 mM IPTG and 0.4% arabinose and grown for another 3 h at 37 °C prior to harvesting and sonication. Lysates were incubated with cobalt-NTA resin, washed, eluted in 500 mM imidazole, and analyzed by western blot.

KEGG ortholog analysis {#S21}
----------------------

The KEGG database Module Ortholog Table was used to identify species encoding orthologs of RcsCDB and BaeSR^[@R58]^. For WigK and WigR, KEGG's SSDB Ortholog function was used to generate alignment SW-scores and those with over 50% of maximum (SW-score alignment against self) were considered orthologs. Only strains encoding both genes of the two-component system (or all three for the RcsCDB Module) were considered to have the orthologous pathway.

Statistics and Reproducibility {#S22}
------------------------------

Statistics were computed using GraphPad Prism software. Exact n, p, and F values for all statistical analyses are provided in linked source data files. For all instances where data pertaining to the same experimental hypothesis are shown in multiple (main and extended data) figures, ANOVA analyses included all comparison groups across all figures to ensure conservative estimates of significance.

Data availability {#S23}
-----------------

Source data linked to figures is provided on the journal webpage. Final structural model was deposited to PDB (6V98). Further information is available from the corresponding author upon reasonable request.

Supplementary Material {#SM1}
======================

Extended Data {#S24}
=============

![Further analyses of TseH killing, delivery, and structure\
**a.** Relative survival (killing by *V. cholerae* V52 TseH^WT^ / TseH^H64A^) of *E. coli, A. hydrophila, Edwardsiella sp., A. baylyi* ADP1 (ΔT6SS), or *V. parahaemolyticus* RIMD2210633 strains. Welch's one-way ANOVA with Dunnett's multiple comparisons test comparing each sample to *E. coli* MG1655; \*, p \< 0.05; \*\*, p \< 0.01; ns, not significant. **b.** Relative survival (killing by TseH^WT^ strain relative to killing by TseH^H64A^ strain) of *A. dhakensis* expressing TsiH or vector only control. Unpaired 2-tailed t-test; \*\*\*, p \< 0.001. **c.** Survival of *A. dhakensis* after killing by TseH^H64A^ strain expressing TseH or vector only. Vector control data resembles no-plasmid data shown in [Fig. 1a](#F1){ref-type="fig"} and was only repeated in duplicate. Unpaired 2-tailed t-test with Welch's correction; \*\*, p \< 0.01. **d.** Extension of [Figure 1b](#F1){ref-type="fig"} in the main text. Survival of *A. dhakensis* prey after killing by ΔPAAR2 strain expressing plasmid-borne TseH and full-length or C-terminal truncations of PAAR2. For PAAR2: V, vector; numbers, PAAR2 truncated to indicated amino acid length; Δin, codons 146-156 removed leaving downstream residues intact. One-way ANOVA with Dunnett's multiple comparisons test comparing to the sample expressing TseH and Vector control of PAAR2; \*\*\*, p \< 0.001; ns, not significant. For all graphs, the mean and standard deviation are shown. Dots show individual replicates. **e.** Western blot showing whole cell lysate or eluted fraction after His-tag pull-down. BL21 DE3 *E. coli* expressed Flag-tagged TseH in combination with either His-tagged PAAR2 or Spy as a non-binding control. Number at left indicated ladder band size in kDa. Data is representative of two independent replicates. **f.** Circular permutation of catalytic residues causes swapping of N- and C-terminal lobes in the structure of TseH compared to Tse1 (PDB: 4EOB^18^), the other T6SS effector that belongs to NlpC/P60 family has reversed N- and C-lobe structure in comparison to TseH. **g.** Restricted access to the catalytic cysteine in certain peptidoglycan endopeptidases. The surface representations of SaCwlT and TseH show that the conformational changes in residues surrounding the active site are necessary for the substrate binding^21,22^. For all graphs, the mean and standard deviation are shown. Dots show individual replicates. TseH^WT^, *V. cholerae* V52 with all anti-bacterial effectors inactivated except TseH; TseH^H64A^, V52 with all anti-bacterial effectors inactivated including TseH.](nihms-1550164-f0007){#F7}

![Identified mutations that reduce TseH toxicity](nihms-1550164-f0008){#F8}

![Additional *E. coli* mutants susceptible to T6SS-delivered TseH\
**a.** Disk diffusion induction of plasmid-borne TAT-tagged TseH expression in bacterial lawns of *E. coli* MG1655. Wild-type (top) or H64A mutant (bottom) TseH are compared. Right disks contain the inducer of expression, arabinose (Ara), and left disks contain the repressor, glucose (Glu). Representative of three independent replicates. **b.** As in **a**, comparing induction of plasmid-borne TAT-tagged TseH^WT^ expression in *E. coli* MG1655 or *A. dhakensis* (ΔT6SS). Similar data for TseH^WT^ in *E. coli* has been shown previously and is shown again here for comparison^4^. **c.** Relative survival (killing by TseH^WT^ / TseH^H64A^) of *E. coli* wild-type or knockout mutants from indicated categories. One-way ANOVA with Dunnett's multiple comparisons test comparing each sample to WT; \*\*, p \< 0.01; \*\*\*, p \< 0.001; ns, not significant. Data for WT (*E. coli*) is shown in [Figure 2](#F2){ref-type="fig"} and is shown again here for comparison. Aux., auxotrophs. **d.** RT-qPCR comparing expression of genes in wild-type *E. coli* prey after T6SS competition assay with TseH^WT^ or TseH^H64A^ killer strains. Value with TseH^H64A^ killer was set to 1 to show fold induction in response to TseH activity upon delivery by the T6SS. One-way ANOVA (with samples shown in [Figure 2d](#F2){ref-type="fig"}) with Sidak's multiple comparisons test; ns, not significant. For both graphs, the mean and standard deviation are shown. Dots show individual replicates. TseH^WT^, *V. cholerae* V52 with all anti-bacterial effectors inactivated except TseH; TseH^H64A^, V52 with all anti-bacterial effectors inactivated including TseH.](nihms-1550164-f0009){#F9}

![Additional data for RcsA and BaeR regulon overexpression, and effect of Spy overexpression on permeability\
**a.** Disk diffusion induction of plasmid-borne TAT-tagged TseH in bacterial lawns of *E. coli* BW25113 containing RcsA or vector only plasmids. IPTG was added throughout the lawn to induce RcsA. Disks contain arabinose to induce TAT-TseH expression. Representative of three independent replicates. **b.** Relative survival (killing by TseH^WT^ / TseH^H64A^) of *E. coli* Δ*degP* mutant or *A. dhakensis* with vector (Vec) or overexpressing genes from the BaeR regulon. One-way ANOVA with Sidak's multiple comparisons test comparing samples to their respective empty vector controls; \*, p \< 0.05; \*\*, p \< 0.01; ns, not significant. Vector controls are shown in [Figure 2](#F2){ref-type="fig"} and are shown again here for comparison. Mean and standard deviations are shown. Dots show individual replicates. pSpy^ΔSec^, plasmid expressing Spy with its Sec secretion tag deleted. **c.** Images of Δ*baeR E. coli* overexpressing plasmid-borne TAT-TseH and either Spy or vector-only controls. The phase-contrast and propidium iodide(PI) channels are merged. Scale bar shows 5 μm. Representative of three independent replicates. **d.** Quantification showing the percent of total cells showing PI+ fluorescence. N number at top indicates total cells counted. Dots show mean results from three independent experiments (used to calculate statistics) and error bars show one standard deviation. Unpaired 2-tailed t-test, p = 0.0513.](nihms-1550164-f0010){#F10}

![Additional data for Δ*wigR* strain T6SS susceptibility, immunity gene expression, VPS-mediated aggregation, and *Aeromonas* species do not encode RcsCDB, BaeSR, or WigKR\
Relative survival (wild-type V52 / TseH^H64A^ killer strain) of *V. cholerae* V52 (T6SS^+^ background) prey (**a.**) or *V. cholerae* C6706 prey (**b.**) with intact (^+^), deleted (Δ), or complemented (Δ,p) *wigR*. Stationary (Stat.) and log phase prey are shown. One-way ANOVA with Sidak's multiple comparisons test; \*\*\*, p \< 0.001; \*\*, p \< 0.01; \*, p \< 0.05; ns, not significant. **c.** RT-qPCR measuring expression of T6SS immunity genes in Δ*wigR V. cholerae* V52 relative to in the *wigR+* strain (both in the ΔT6SS background). For all graphs, the mean and standard deviation are shown. Dots show individual replicates. **d.** Image showing settling of *V. cholerae* V52 grown at 37 °C or at 30 °C to induce VPS synthesis. Image after vortexing to disrupt aggregates is also shown for comparison (lower panel). Representative of three independent replicates. **e.** KEGG ortholog analysis across Gammaproteobacteria. KEGG Modules were compared for RcsCDB and BaeSR. WigK and WigR orthologs were assessed by sequence homology to VCA0565 and VCA0566 using an SW-score cutoff of 50% of maximum. Data is shown as the percentage of strains within each taxonomic group that contain an ortholog of all genes in the loci. Number in brackets indicates the number of strains in the taxonomic group in the KEGG database.](nihms-1550164-f0011){#F11}

![Table of data collection, phasing and refinement statistics for MAD (SeMet) structures.](nihms-1550164-f0012){#F12}
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![TseH is an NlpC/P60 peptidase delivered by PAAR2 that kills *A. dhakensis* but not *E. coli* or *V. cholerae*.\
**a.** T6SS competition assay wherein *E. coli*, *A. dhakensis* , or *V. cholerae* Δ*tsiH* prey were subjected to killing by wild-type (WT) or catalytically inactive (H64A) TseH delivered from V52 with all other anti-bacterial effectors inactivated. One-way ANOVA with Sidak's multiple comparisons test comparing each sample to the same prey killed by the TseH^H64A^ strain; \*\*\*, p \< 0.001; ns, not significant. DL, detection limit. **b.** Survival of *A. dhakensis* prey after killing by ΔPAAR2 (in TseH^WT^ background) strain expressing plasmid-borne TseH and/or PAAR2. V, vector control; One-way ANOVA with Dunnett's multiple comparisons test comparing to the sample expressing TseH and Vector control of PAAR2; \*\*\*, p \< 0.001; ns, not significant. Graphs show the mean of at least three independent replicates and error bars show one standard deviation. Dots show individual replicates. WT, wild-type V52; TseH^WT^, V52 with all anti-bacterial effectors inactivated except TseH; TseH^H64A^, V52 with all anti-bacterial effectors inactivated including TseH. **c.** Crystal structure of TseH. Brown highlights conserved regions identified previously^[@R4]^. C172 was modified by a cacodylate ion in the crystal structure but is illustrated in stick format without the modification for illustration purpose. The area cleaved by thermolysin is depicted as a dotted line. **d.** Putative substrate binding pocket of TseH. The catalytic triad is shown as a stick model. The loop covering the active site (pink) is stabilized by the hydrogen bonding interaction (yellow dotted line) between Arg84 side chain and backbone carbonyls of Val39 and Ala40. Val39 side chain is not shown for illustration purpose.](nihms-1550164-f0001){#F1}

![Envelope stress responses protect *E. coli* against T6SS-mediated killing.\
**a.** Relative survival (killing by TseH^WT^ / TseH^H64A^) of *E. coli* wild-type or knockout mutants. One-way ANOVA with Dunnett's multiple comparisons test comparing each sample to WT; \*\*\*, p \< 0.001; ns, not significant. **b.** Relative survival of *E. coli* Δ*rcsB* or Δ*baeR* mutants with empty vector (Vec) or complementation plasmids. One-way ANOVA with Sidak's multiple comparisons test comparing samples to their respective empty vector controls; \*, p \< 0.05. **c.** Relative survival of select *E. coli* mutants involved in envelope integrity (Env.) or the RcsB and BaeR regulons. One-way ANOVA with Dunnett's multiple comparisons test comparing each sample to WT; \*\*, p \< 0.01; \*\*\*, p \< 0.001; ns, not significant. WT (*E. coli*) data is the same as in **a.** and is shown again for comparison. **d.** RT-qPCR comparing expression of the Rcs-regulated *wza* gene in wild-type *E. coli* prey after T6SS competition assay with TseH^WT^ or TseH^H64A^ killer strains. Value with TseH^H64A^ killer was set to 1 to show fold induction in response to TseH activity upon delivery by the T6SS. One-way ANOVA (with samples shown in [Extended Data Fig. 3d](#SD1){ref-type="supplementary-material"}) with Sidak's multiple comparisons test; \*\*\*, p \< 0.001. **e.** Relative survival (killing by V52 wild-type / ΔT6SS) of *E. coli* wild-type or Δ*wcaJ* prey overexpressing empty vector or RcsA to induce colanic acid synthesis. Killer and prey strains were mixed at a 1:1 ratio. One-way ANOVA with Tukey's multiple comparisons test; \*\*, p \< 0.01. DL, detection limit. **f.** Relative survival (killing by TseH^WT^ / TseH^H64A^) of *E. coli* mutants with empty vector or expression plasmids. One-way ANOVA with Sidak's multiple comparisons test comparing samples to their respective empty vector controls; \*\*, p \< 0.01; \*\*\*, p \< 0.001; ns, not significant. Graphs show the mean of at least three independent replicates and error bars show one standard deviation. Dots show results from individual replicates. TseH^WT^, V52 with all anti-bacterial effectors inactivated except TseH; TseH^H64A^, V52 with all anti-bacterial effectors inactivated including TseH.](nihms-1550164-f0002){#F2}

![*V. cholerae* WigR is necessary to survive T6SS self-killing, independent of immunity genes.\
**a.** Induction of TAT-tagged TseH in V52 with intact or deleted *tsiH* and *wigR*. Representative of three independent replicates. **b.** Relative survival (V52 TseH^WT^ / TseH^H64A^ killer strain) of *V. cholerae* V52 prey with intact or deleted *tsiH* and *wigR*. Welch's one-way ANOVA with Games-Howell test; \*, p \< 0.05; ns, not significant. For Δ*tsiH*Δ*wigR* compared to *tsiH*^*+*^*wigR*^*+*^ and *tsiH*^*+*^Δ*wigR* prey, p \< 0.05. **c.** Relative survival (wild-type V52 / TseH^H64A^ killer strain) of stationary (Stat.) and log phase V52 prey with intact (+), deleted (Δ), or plasmid complemented (p) *wigR*. One-way ANOVA with Sidak's test; \*\*\*, p \< 0.001. Comparing stationary and log phase, p \< 0.001 for *wigR*^*+*^ and Δ*wigR,* not significant for complemented strain. **d.** Relative survival (wild-type V52 / ΔT6SS killer strain) of *V. cholerae* V52 prey lacking the *tsiV1*, *tsiV2* and *tsiV3* immunity genes (Δimm background) with intact (+), deleted (Δ), or complemented (p) *wigR*. Stationary (Stat.) or log phase prey were used at a 1:5 killer:prey ratio. One-way ANOVA with Sidak's multiple comparisons test; \*\*\*, p \< 0.001; \*\*, p \< 0.01. **e.** Relative survival (killing by *A. dhakensis* SSU wild-type / ΔT6SS) of *V. cholerae* V52 prey (ΔT6SS background) with intact (+), deleted (Δ), or complemented (p) *wigR*. Log phase prey were used at a 1:1 killer:prey ratio. One-way ANOVA with Sidak's multiple comparisons test; \*\*\*, p \< 0.001; \*\*, p \< 0.01. Graphs show the mean of at least three independent replicates, error bars show standard deviation. Dots show individual replicates. *tsiH*^*+*^ prey in **a** and **b**, and all prey in **c** and **e** are in ΔT6SS V52 background. DL, detection limit.](nihms-1550164-f0003){#F3}

![The protective role of WigKR supersedes VPS expression.\
**a.** Relative survival (killing by V52 wild-type / ΔT6SS) of *V. cholerae* V52 immunity gene mutant prey encoding or lacking *vpsA* (and therefore VPS). VPS expression was induced by growth of prey strains at 30 °C. One-way ANOVA with Sidak's multiple comparisons test; \*\*\*, p \< 0.001. **b.** Relative survival (killing by *A. dhakensis* SSU wild-type / ΔT6SS) of *V. cholerae* V52 (ΔT6SS background) encoding or lacking *vpsA*. VPS expression was induced by pre-growth of prey strains at 30 °C. One-way ANOVA with Sidak's multiple comparisons test; \*\*\*, p \< 0.001. **c.** Relative survival (killing by wild-type V52 / ΔT6SS) of log phase *V. cholerae* V52 prey with intact (+) or deleted (Δ) *wigR* and *vpsA* genes. As indicated, prey were grown at 37 °C or at 30 °C to induce VPS expression. One-way ANOVA with Sidak's multiple comparisons test; \*\*, p \< 0.01; ns, not significant. DL, detection limit. Graphs show the mean of at least three independent replicates and error bars show one standard deviation. Dots show results from individual replicates.](nihms-1550164-f0004){#F4}

![WigR regulates the T6SS in V52.\
**a.** Relative survival of *E. coli* prey after killing by V52 with intact (WT), deleted (Δ), or plasmid complemented (Δ,p) *wigR*. One-way ANOVA with Tukey's test; \*\*\*, p \< 0.001. DL, detection limit. **b.** Phase contrast (right) and VipA-GFP T6SS assembly (left) in V52 with intact (WT), deleted (Δ), or complemented (Δ,p) *wigR.* Representative of three independent replicates. Scale bar, 2 μm. **c.** Expression of main (*vipA*) and auxiliary (*hcp*) T6SS operons in wild-type (*wigR*^*+*^) or Δ*wigR* V52. One-way ANOVA with Sidak's test; \*\*, p \< 0.01. Graphs show the mean of at least three independent replicates, error bars show standard deviation. Dots show individual replicates.](nihms-1550164-f0005){#F5}

![Envelope stress responses defend against T6SS system attack.\
Model depicting an attacking T6SS delivering toxic effectors such as TseH. The Rcs phosphorelay and BaeSR (in *E. coli*) or WigKR (in *V. cholerae*) two-component systems induce their respective regulons. The induced genes play various roles in protection, including inducing EPS to deflect further T6SS attacks, and mitigating effector-mediated damage. WigR also induces T6SS expression in *V. cholerae*, potentially instigating counter attacks. EPS, exopolysaccharide; PG, peptidoglycan.](nihms-1550164-f0006){#F6}
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